While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically ...

Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...

J.P. Morgan is hosting a three-panel women's health series at this year's conference to highlight the importance of innovation and growing visibility around women's health.

Maintaining a healthy body weight is essential for overall well-being, and many people are actively seeking natural solutions ...

Lipozem is a natural supplement specifically made to offer weight loss benefits to those struggling with stubborn body weight ...

The vaccine will target triple-negative breast cancer. If approved by the FDA, the vaccine will enter its second stage of the trial this year.

In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing Phase 2a trial in focal epilepsy; restricted ...

These amendments represent the first significant changes to “healthy” labeling requirements in 30 years. In its new scheme, ...

The Food and Drug Administration (FDA) recently issued a Notice announcing the availability of an updated final guidance for the industry ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

On January 6, the FDA announced the availability of draft guidance on accelerated approval for drugs and biological products, and consideration ...